David Scott Moore - Net Worth and Insider Trading
David Scott Moore Net Worth
The estimated net worth of David Scott Moore is at least $289,261 dollars as of 2026-09-10. David Scott Moore is the Director of Corvus Pharmaceuticals Inc and owns about 21,700 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $289,261. Details can be seen in David Scott Moore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Scott Moore has not made any transactions after 2026-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Scott Moore
David Scott Moore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Scott Moore owns 1 companies in total, including Corvus Pharmaceuticals Inc (CRVS) .
Click here to see the complete history of David Scott Moore’s form 4 insider trades.
Insider Ownership Summary of David Scott Moore
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2026-06-11 | director |
David Scott Moore Latest Holdings Summary
David Scott Moore currently owns a total of 1 stock. David Scott Moore owns 21,700 shares of Corvus Pharmaceuticals Inc (CRVS) as of June 11, 2026, with a value of $289,261.
Latest Holdings of David Scott Moore
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2026-06-11 | 21,700 | 13.33 | 289,261 |
Holding Weightings of David Scott Moore
David Scott Moore Form 4 Trading Tracker
According to the SEC Form 4 filings, David Scott Moore has made a total of 1 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 21,700 shares on June 11, 2026, which cost David Scott Moore around $250,201.
Insider Trading History of David Scott Moore
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
David Scott Moore Trading Performance
GuruFocus tracks the stock performance after each of David Scott Moore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Scott Moore is 14.91%. GuruFocus also compares David Scott Moore's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Scott Moore within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Scott Moore's insider trading performs compared to the benchmark.
Performance of David Scott Moore
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 35.09 |  | | | | |
| Relative Return to S&P 500(%) | 32.64 | | | | | |
David Scott Moore Ownership Network
Ownership Network List of David Scott Moore
Ownership Network Relation of David Scott Moore
David Scott Moore Owned Company Details
What does Corvus Pharmaceuticals Inc do?
Who are the key executives at Corvus Pharmaceuticals Inc?
David Scott Moore is the director of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , director & 10 percent owner Peter A. Thompson , and See Remarks William Benton Jones .
Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary
Over the past 18 months, David Scott Moore made 1 insider transaction in Corvus Pharmaceuticals Inc (CRVS) with a net purchase of 21,700. Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net sale of 1,176,332 shares made by Orbimed Advisors Llc , a net sale of 1,176,332 shares made by Peter A. Thompson , and a net purchase of 6,932 shares made by Miller Richard A Md .
In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 21,700 shares, with a net purchase of 21,700 shares. During the past 18 months, 2,352,664 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 28,632 shares were bought by its insiders, resulting in a net sale of 2,324,032 shares.
Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corvus Pharmaceuticals Inc Insider Transactions
David Scott Moore Mailing Address
Above is the net worth, insider trading, and ownership report for David Scott Moore. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Scott Moore's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
